Interims why not?

Resourcing Skills Gaps with Flexible Support   LIFE SCIENCES ORGANISATIONS are committed to improving the health and well-being of a global population. While the industry has taken huge strides to conquer major diseases and improve quality of life, significant opportunities remain to meet the needs across several patient communities.

The industry faces major economic and operational challenges if it is to capitalise on these opportunities and create more value for healthcare payers, providers and patients. As societies age and emerging economies become more affluent, consumers will demand more and better medical care. Companies will need to spread their portfolios globally to become more competitive in their search for innovative health solutions.

Regulatory controls, market access and pricing, together with improvements in science and technology will all increase complexity and opportunity. I find that many pharmaceutical companies face skills gaps across their organisations. Some don’t have the right people in place, which, combined with freezes on permanent recruitment means that more junior employees have to take on more complex work that they may not yet be ready for.

How do such companies find the skills they need and solve their business problems quickly?

Our answer: use an Interim Manager.

There are currently key drivers and trends in supply and demand of Interims to the global life sciences industry. In terms of the most sought after professionals, we have found that there is great demand for medical, regulatory affairs and market access roles. Some markets are more mature than others and there are still opportunities for experienced, well qualified professionals to help companies meet the challenges ahead. With life sciences companies having to adapt to additional regulatory controls, permanent employees have to take on extra responsibility.

HR directors need to push back and utilise the value added talent available with Interim Managers. We have seen some organisations – particularly the spin outs and biotech community in addition to medical devices and mainstream pharmaceutical companies – making the most of this. Increased globalisation can also be an issue when recruiting permanent employees.

Companies who conduct operations in a number of countries can choose an interim manager for a defined period without the need for relocation costs. Interim Managers can help companies meet these international requirements swiftly and cost-effectively, without any external training requirement.

We believe that life science companies have really seen the value in recent years that high quality, flexible support can bring. When building a post-recession leadership team and preparing for a new competitive climate, we are of the opinion that modern organisations cannot afford to rely on outdated job descriptions that seek skills no longer relevant to an organisation. The utilisation of multi-skilled and highly experienced senior Interim Managers can provide an immediate solution to an ever-growing problem.

PiR are leaders in senior life science resourcing. For more news and information, you can follow us on Twitter and LinkedIn 

Leave a Reply